Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18162120> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Q18162120 subject Q7151811.
- Q18162120 subject Q8397992.
- Q18162120 subject Q8431776.
- Q18162120 abstract "cAd3-ZEBOV (also known as the NIAID/GSK Ebola vaccine or cAd3-EBO Z) is an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID). This vaccine is derived from a chimpanzee adenovirus, Chimp Adenovirus type 3 (ChAd3), genetically engineered to express glycoproteins from the Zaire and Sudan species of ebolavirus to provoke an immune response against them. Simultaneous phase 1 trials of this vaccine commenced in September 2014, being administered to volunteers in Oxford and Bethesda. During October the vaccine is being administered to a further group of volunteers in Mali. If this phase is completed successfully, the vaccine will be fast tracked for use in the Ebola virus epidemic in West Africa. In preparation for this, GSK is preparing a stockpile of 10,000 doses.".
- Q18162120 wikiPageWikiLink Q10538943.
- Q18162120 wikiPageWikiLink Q134808.
- Q18162120 wikiPageWikiLink Q15989108.
- Q18162120 wikiPageWikiLink Q17486688.
- Q18162120 wikiPageWikiLink Q18085856.
- Q18162120 wikiPageWikiLink Q187126.
- Q18162120 wikiPageWikiLink Q193447.
- Q18162120 wikiPageWikiLink Q212322.
- Q18162120 wikiPageWikiLink Q30612.
- Q18162120 wikiPageWikiLink Q326276.
- Q18162120 wikiPageWikiLink Q34433.
- Q18162120 wikiPageWikiLink Q3519875.
- Q18162120 wikiPageWikiLink Q5331908.
- Q18162120 wikiPageWikiLink Q7151811.
- Q18162120 wikiPageWikiLink Q7633352.
- Q18162120 wikiPageWikiLink Q80174.
- Q18162120 wikiPageWikiLink Q8397992.
- Q18162120 wikiPageWikiLink Q8431776.
- Q18162120 wikiPageWikiLink Q912.
- Q18162120 wikiPageWikiLink Q918396.
- Q18162120 type ChemicalSubstance.
- Q18162120 type Drug.
- Q18162120 type ChemicalObject.
- Q18162120 type Thing.
- Q18162120 type Q8386.
- Q18162120 comment "cAd3-ZEBOV (also known as the NIAID/GSK Ebola vaccine or cAd3-EBO Z) is an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID). This vaccine is derived from a chimpanzee adenovirus, Chimp Adenovirus type 3 (ChAd3), genetically engineered to express glycoproteins from the Zaire and Sudan species of ebolavirus to provoke an immune response against them.".
- Q18162120 label "CAd3-ZEBOV".